Is First-Line mTNBC Changing? Datopotamab Deruxtecan vs Sacituzumab Govitecan Explained - Dr. Bill Gradishar & Dr. Tiffany Traina episode artwork

EPISODE · Jan 2, 2026 · 20 MIN

Is First-Line mTNBC Changing? Datopotamab Deruxtecan vs Sacituzumab Govitecan Explained - Dr. Bill Gradishar & Dr. Tiffany Traina

from Community Health Media · host Community Health Media

In this deep-dive conversation, Dr. Bill Gradishar and Dr. Tiffany Traina break down two pivotal first-line trials reshaping treatment for metastatic triple-negative breast cancer.They explore TROPION-Breast02 and ASCENT-03, unpacking progression-free survival, overall survival, response rates, toxicity profiles, and what truly differentiates datopotamab deruxtecan from sacituzumab govitecan in real-world practice.From refractory disease and disease-free interval definitions to logistics, crossover design, brain metastases, and patient-centered decision-making, this discussion offers practical insight into how clinicians should think about therapy selection, sequencing, and shared decision-making in mTNBC today.🎧 A must-watch episode for oncologists navigating the rapidly evolving TNBC treatment landscape.#TripleNegativeBreastCancer #TNBC #Oncology #BreastCancer #AntibodyDrugConjugates #ADCs #Datopotamab #Sacituzumab #CancerResearch #MedicalOncology #ClinicalTrials #PrecisionOncology #CommunityHealthMedia–Thanks for watching!Our podcasts are also available on: • Spotify - https://spotf.fi/chm-podcast • Amazon Music - https://amazn.so/chm-podcast • Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248 • Castbox - https://castbox.fm/vh/6735434 • Goodpods - https://goodpods.com/profile/chm-111066 • iHeartRadio - https://iheart.com/podcast/291542082 • Pocket Casts - https://pca.st/3ncdh11o–Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.We specialize in: • Peer to peer interviews, panels & round-tables • Curated live events & conferences • Professional in-depth content & research updates • Interactive learning modules & webinars • Live & on-demand webcasts & podcastsLearn more about us here - https://communityhealth.media

Episode metadata supplied by the publisher feed · Published Jan 2, 2026

Embed this episode

Ready to play

Is First-Line mTNBC Changing? Datopotamab Deruxtecan vs Sacituzumab Govitecan Explained - Dr. Bill Gradishar & Dr. Tiffany Traina

0:00 20:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Community Health Media?

This episode is 20 minutes long.

When was this Community Health Media episode published?

This episode was published on January 2, 2026.

Can I download this Community Health Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!